Oppenheimer & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.08M | Buy |
|
|||||
|
2025
Q1 | $2.14M | Buy |
|
|||||
|
2024
Q4 | $2.59M | Sell |
|
|||||
|
2024
Q3 | $2.22M | Buy |
|
|||||
|
2024
Q2 | $2.37M | Buy |
|
|||||
|
2024
Q1 | $2.34M | Sell |
|
|||||
|
2023
Q4 | $2.26M | Buy |
|
|||||
|
2023
Q3 | $1.9M | Buy |
|
|||||
|
2023
Q2 | $1.55M | Buy |
|
|||||
|
2023
Q1 | $1.67M | Sell |
|
|||||
|
2022
Q4 | $2.39M | Buy |
|
|||||
|
2022
Q3 | $1.97M | Buy |
|
|||||
|
2022
Q2 | $1.2M | Buy |
|
|||||
|
2022
Q1 | $1.14M | Sell |
|
|||||
|
2021
Q4 | $1.05M | Buy |
|
|||||
|
2021
Q3 | $562K | Buy |
|
|||||
|
2021
Q2 | $553K | Buy |
|
|||||
|
2021
Q1 | $379K | Sell |
|
|||||
|
2020
Q4 | $375K | Buy |
|
|||||
|
2020
Q3 | $364K | Buy |
|
|||||
|
2020
Q2 | $369K | Sell |
|
|||||
|
2020
Q1 | $286K | Sell |
|
|||||
|
2019
Q4 | $706K | Buy |
|
|||||
|
2019
Q3 | $537K | Buy |
|
|||||
|
2019
Q2 | $227K | Sell |
|
|||||
|
2019
Q1 | $607K | Buy |
|
|||||
|
2018
Q4 | $365K | Sell |
|
|||||
|
2018
Q3 | $792K | Buy |
|
|||||
|
2018
Q2 | $332K | Sell |
|
|||||
|
2018
Q1 | $293K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $124K | Buy |
|